Barr Plans To Boost Generic Oral Contraceptive Through Promotion Of Organon's Mircette
This article was originally published in The Pink Sheet Daily
Executive Summary
A proposed $155 mil. deal would give Barr the NDA for Organon's oral contraceptive and settle ongoing patent litigation related to Barr's Mircette generic.